HashiCorp (HCP)
(Delayed Data from NSDQ)
$33.93 USD
+0.05 (0.15%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $33.93 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth B Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$33.93 USD
+0.05 (0.15%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $33.93 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth B Momentum D VGM
Zacks News
HashiCorp, Inc. (HCP) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for HashiCorp, Inc. (HCP) give a sense of how the business performed in the quarter ended October 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
HashiCorp, Inc. (HCP) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
HashiCorp, Inc. (HCP) delivered earnings and revenue surprises of 175% and 1.97%, respectively, for the quarter ended October 2023. Do the numbers hold clues to what lies ahead for the stock?
HashiCorp, Inc. (HCP) Moves 12.1% Higher: Will This Strength Last?
by Zacks Equity Research
HashiCorp, Inc. (HCP) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
HashiCorp, Inc. (HCP) Surges 5.5%: Is This an Indication of Further Gains?
by Zacks Equity Research
HashiCorp, Inc. (HCP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
HashiCorp, Inc. (HCP) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
HashiCorp, Inc. (HCP) delivered earnings and revenue surprises of 33.33% and 3.53%, respectively, for the quarter ended July 2023. Do the numbers hold clues to what lies ahead for the stock?
8x8 (EGHT) Q1 Earnings and Revenues Lag Estimates
by Zacks Equity Research
8x8 (EGHT) delivered earnings and revenue surprises of -7.14% and 1.94%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
HashiCorp, Inc. (HCP) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
HashiCorp, Inc. (HCP) delivered earnings and revenue surprises of 50% and 3.66%, respectively, for the quarter ended April 2023. Do the numbers hold clues to what lies ahead for the stock?
Porch Group, Inc. (PRCH) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Porch Group, Inc. (PRCH) delivered earnings and revenue surprises of -5.41% and 30.45%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Alkami Technology (ALKT) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Alkami (ALKT) delivered earnings and revenue surprises of 20% and 2.21%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
HashiCorp, Inc. (HCP) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
HashiCorp, Inc. (HCP) delivered earnings and revenue surprises of 68.18% and 9.20%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?
MongoDB (MDB) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
MongoDB (MDB) delivered earnings and revenue surprises of 714.29% and 7.59%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?
Box (BOX) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Box (BOX) delivered earnings and revenue surprises of 8.82% and 0.07%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?
Applied Materials (AMAT) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Applied Materials (AMAT) delivered earnings and revenue surprises of 5.18% and 0.80%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?
Wall Street Analysts Think HashiCorp, Inc. (HCP) Could Surge 67%: Read This Before Placing a Bet
by Zacks Equity Research
The mean of analysts' price targets for HashiCorp, Inc. (HCP) points to a 67.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Wall Street Analysts Believe HashiCorp, Inc. (HCP) Could Rally 56%: Here's is How to Trade
by Zacks Equity Research
The mean of analysts' price targets for HashiCorp, Inc. (HCP) points to a 56.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Why Is Coupa Software (COUP) Down 2.3% Since Last Earnings Report?
by Zacks Equity Research
Coupa Software (COUP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Wall Street Analysts See a 58% Upside in HashiCorp, Inc. (HCP): Can the Stock Really Move This High?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 57.8% in HashiCorp, Inc. (HCP). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
HCP Tops Q3 FFO Estimate, Changes Name to Healthpeak Properties
by Zacks Equity Research
HCP, now renamed Healthpeak Properties, puts up an impressive show in third-quarter 2019 on the back of growth in the life-science and medical-office segments' net operating income.
MGP vs. HCP: Which Stock Is the Better Value Option?
by Zacks Equity Research
MGP vs. HCP: Which Stock Is the Better Value Option?
HCP (HCP) Q3 FFO and Revenues Surpass Estimates
by Zacks Equity Research
HCP (HCP) delivered FFO and revenue surprises of 2.33% and 5.82%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Alexandria (ARE) Q3 FFO Meets Estimates, Rental Rate Grows
by Zacks Equity Research
Alexandria Real Estate Equities' (ARE) Q3 results reflect decent internal and external growth, as well as continued strong leasing activity and rental-rate growth in the quarter.
Will Growth in Seniors Housing Market Aid HCP's Q3 Earnings?
by Zacks Equity Research
While HCP's Q3 results will likely reflect benefits of higher occupancy in the U.S. seniors housing market, a decline in income from direct financing lease might have impacted its revenue growth.
HCP Announces Strategic Portfolio Trades With Brookdale
by Zacks Equity Research
HCP's mutually-beneficial agreement with Brookdale reduces the operator's concentration in the company's portfolio to 8% and enables transitions to Life Care Services under a highly-incentivized contract.
Encouraging Near-Term Outlook for Equity REIT Stocks
by Moumita Chattopadhyay
With market dynamics of individual asset categories playing crucial roles in determining performance and economic indicators looking decent, REIT stocks have scope to excel.
HCP to Buy Life Science Asset, Boost West Cambridge Cluster
by Zacks Equity Research
Delivering on its strategy to expand presence in the Boston region, HCP will acquire a trophy life science property -- 35 CambridgePark Drive -- for $332.5 million.